Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

Jan Bolinder, Östen Ljunggren, Joel Kullberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 860 citations

Medicine, Endocrinology, Pharmacology +17

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

Clifford J. Bailey, Jorge Luiz Gross, Anne Pieters et al. · The Lancet · 2010 · 857 citations

Medicine, Pharmacology, Pharmacotherapy +13

Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes

Hiddo J.L. Heerspink, Dick de Zeeuw, Li Wie et al. · Diabetes Obesity and Metabolism · 2013 · 831 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise

Ele Ferrannini, Silvia Ramos, Afshin Salsali et al. · Diabetes Care · 2010 · 712 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

James F. List, Vincent Woo, Enrique Morales et al. · Diabetes Care · 2008 · 696 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17